By Sonshine Wiley
Social Media gives us access to the family and friends we aren’t able to see all the time. It provides a way for us to access people within the networks of those friends and families as well. Sometimes we are completely blown away by the amazing connections we are able to make, and then there are the times we are totally not on board with a someone’s personality. This is the power of having a choice to friend and unfriend whomever is within your reach.
So, what happens when you are a 35 year old woman who’s new suggested friend happens to be your rapist from when you were an 8 year old little girl? This is not an uncommon occurrence, and many are faced with the decision to run and tell the world about this horrible person or (for fear that many will defend and victim blame) hide in the shadows afraid that this person still has the power.
How many times has someone who committed horrible acts been exonerated by the public because to those people this person is a “good person”? Our society no longer yields to moral compass and accountability, but to public opinion. However, in an effort to support victims, there are resources available to assist with instances such as this both on and off social media platforms.
The ability to block the person and all of their mutual connections is available as well as emotional support through therapy and online support groups. Seeking out these options may not bring a person to further accountability, but it does save the victim from suffering more than they already have. In addition, making sure the act is reported to the proper authorities so that justice is served can provide a solution.
Every voice that speaks in truth contributes to this solution. Breaking the silence could potentially keep this from happening to others.
Michelle Williams of Destiny's Child fame has always been open about her mental health. She has been struggling with issues of depression for quite a while, but now she is seeking professional help with her illness.
According to TMZ, the Destiny's Child member checked herself into a mental health facility outside of Los Angeles a few days ago.
"For years I have dedicated myself to increasing awareness of mental health and empowering people to recognize when it's time to seek help, support and guidance from those that love and care for your well being," she said in a statement on Twitter Tuesday (July 17).
In an interview with The Talk in 2017, the songstress admitted that at times she was suicidal, particularly during the peak of Destiny's Child's success. She continues to stand up against the stigma toward mental health.
We wish he success in her pursuit of good mental health.
By Sonshine Wiley
Rejection is the Silent Killer.
Rejection is scientifically proven to be linked to feelings of physical pain. Those of us who do not handle rejection well often tend to bury the feelings associated in order to avoid that pain. Although this is ineffective, it is a continued practice for many.
Creating a plan of action to combat those moments can literally save your life. Rejection is one of the leading causes of depression. Some are not able to recover from this, and end their lives. Instead of waiting until backed into a corner to start dealing with those feelings, seeking professional help for challenging times has become more prevalent. Many are also finding things that create an atmosphere of gratitude in their lives to support a lasting change. As we all know eventually tough times will come, however, combating negative self talk and increased self care seems to have improved the quality of life for many.
Monday was a historic day for cannabis and the FDA. For the first time in the departments history, the FDA has approved a cannabis-based drug.
The luck drug, Epidiolex, was recommended for approval by an advisory committee in April, and the agency had until this week to make a decision.
The twice-daily oral solution is approved for use in patients 2 and older to treat two types of epileptic syndromes: Dravet syndrome, a rare genetic dysfunction of the brain that begins in the first year of life, and Lennox-Gastaut syndrome, a form of epilepsy with multiple types of seizures that begin in early childhood, usually between 3 and 5.
The drug is the "first pharmaceutical formulation of highly-purified, plant-based cannabidiol (CBD), a cannabinoid lacking the high associated with marijuana, and the first in a new category of anti-epileptic drugs," according to a statement Monday from GW Pharmaceuticals, the UK-based biopharmaceutical company that makes Epidiolex.
Cannabidiol is one of more than 80 active cannabinoid chemicals, yet unlike tetrahydrocannabinol, or THC, it does not produce a high.
The European Medical Society is also considering approval of Epidiolex and is expected to announce a decision in the first quarter of next year.